Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Smith

Showing results (141-150 of 202) with videos related to

Pageof 21
Sort By:
BMJ Global Health|May 20, 2021
Novel vaccine safety issues and areas that would benefit from further researchDaniel A Salmon, Paul Henri Lambert, Hanna M Nohynek, et al.
Journal of Medicinal Chemistry|September 17, 2004
Resistance-modifying agents. 11.(1) Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to alpha1-acid glycoproteinNicola J Curtin, Hannah C Barlow, Karen J Bowman, et al.
Health Technology Assessment (Winchester, England)|July 25, 2017
Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UKPunam Mangtani, Patrick Nguipdop-Djomo, Ruth H Keogh, et al.
Annals of Clinical Microbiology and Antimicrobials|January 11, 2007
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, UgandaHamidou Traore, Sam Ogwang, Kim Mallard, et al.
Vaccine|October 28, 2008
First generation leishmaniasis vaccines: a review of field efficacy trialsSassan Noazin, Farrokh Modabber, Ali Khamesipour, et al.
International Journal of Epidemiology|October 13, 2017
The duration of protection of school-aged BCG vaccination in England: a population-based case-control studyPunam Mangtani, Patrick Nguipdop-Djomo, Ruth H Keogh, et al.
Vaccine|April 30, 2019
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultationsJohan Vekemans, Jonathan Crofts, Carol J Baker, et al.
The Journal of Biological Chemistry|October 5, 2019
The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activityTuong-Vi Nguyen, Shihua Yao, Yahong Wang, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Molecular Cancer Therapeutics|January 17, 2012
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myelomaDouglas W McMillin, Hannah M Jacobs, Jake E Delmore, et al.
Pageof 21

Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
BMJ Global Health|May 20, 2021
Novel vaccine safety issues and areas that would benefit from further researchDaniel A Salmon, Paul Henri Lambert, Hanna M Nohynek, et al.
Journal of Medicinal Chemistry|September 17, 2004
Resistance-modifying agents. 11.(1) Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to alpha1-acid glycoproteinNicola J Curtin, Hannah C Barlow, Karen J Bowman, et al.
Health Technology Assessment (Winchester, England)|July 25, 2017
Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UKPunam Mangtani, Patrick Nguipdop-Djomo, Ruth H Keogh, et al.
Annals of Clinical Microbiology and Antimicrobials|January 11, 2007
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, UgandaHamidou Traore, Sam Ogwang, Kim Mallard, et al.
Vaccine|October 28, 2008
First generation leishmaniasis vaccines: a review of field efficacy trialsSassan Noazin, Farrokh Modabber, Ali Khamesipour, et al.
International Journal of Epidemiology|October 13, 2017
The duration of protection of school-aged BCG vaccination in England: a population-based case-control studyPunam Mangtani, Patrick Nguipdop-Djomo, Ruth H Keogh, et al.
Vaccine|April 30, 2019
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultationsJohan Vekemans, Jonathan Crofts, Carol J Baker, et al.
The Journal of Biological Chemistry|October 5, 2019
The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activityTuong-Vi Nguyen, Shihua Yao, Yahong Wang, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Molecular Cancer Therapeutics|January 17, 2012
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myelomaDouglas W McMillin, Hannah M Jacobs, Jake E Delmore, et al.
Pageof 21